Navigation Links
Talecris Names John Perkins as Executive Vice President, Global Commercial Operations

RESEARCH TRIANGLE PARK, N.C., June 3 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced the promotion of John R. Perkins to the position of executive vice president, global commercial operations.

In this leadership position, Perkins will be responsible for the global commercial business, including worldwide portfolio management, sales and marketing.

"John has demonstrated strong leadership and a proven track record of success," said Lawrence D. Stern, chairman and CEO of Talecris. "I am confident that his experience and diverse skill set will enable the seamless development and execution of our global strategies to drive global growth."

Perkins joined Talecris Biotherapeutics in 2006 and most recently served as the senior vice president and general manager, portfolio management and U.S. business.  He also serves on the board of directors for Centric Health Resources.

Prior to joining Talecris, Perkins was an operations executive at Cerberus Capital. He previously held a variety of positions at General Electric in corporate business development (M&A), marketing and product management, sales, operations and corporate audit.

Perkins received his Bachelor of Arts degree from DePauw University and his Master of Business Administration degree from Northwestern University's Kellogg School of Management.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation. Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.

SOURCE Talecris Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
2. Talecris Added to NASDAQ Biotechnology Index
3. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
4. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
5. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
6. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
7. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
9. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
10. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
11. Thomson Reuters Names the Worlds Hottest Researchers
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
Breaking Biology Technology:
(Date:10/4/2017)... 4, 2017  GCE Solutions, a global clinical research organization (CRO), ... anonymization solution on October 4, 2017. Shadow is designed to assist ... with policy 0070 of the European Medicines Agency (EMA) in meeting ... ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 ... a leader in dairy research, today announced a new ... help reduce the chances that the global milk supply ... this dairy project, Cornell University has become the newest ... Food Supply Chain, a food safety initiative that includes ...
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
Breaking Biology News(10 mins):